Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate CancerKaren E Hoffman, K Ranh Voong, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trialKaren E Hoffman, K Ranh Voong, Thomas J Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2012
PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy eraSean E McGuire, Andrew K Lee, Jasmina Z Cerne, et al.
Diabetes|July 14, 2018
miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in ObesityEun-Hee Koh, Natasha Chernis, Pradip K Saha, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2013
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancerThomas J Pugh, Mark F Munsell, Seungtaek Choi, et al.
Brachytherapy|July 20, 2020
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapyDavid Boyce-Fappiano, Tharakeswara K Bathala, Rong Ye, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapySean E McGuire, Ana M Gonzalez-Angulo, Eugene H Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical TrialsJohn Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Pageof 6